Double maintains 7 strategies that include RMD - ResMed, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
EXPO | 45.17% | $4.08B | -2.17% | 1.43% |
APPF | 45.12% | $7.85B | -7.80% | 0.00% |
ULH | 34.97% | $702.42M | -26.01% | 1.60% |
ROG | 33.46% | $1.38B | -36.97% | 0.00% |
ABT | 32.00% | $219.88B | +13.69% | 1.77% |
LHX | 31.72% | $39.53B | -1.53% | 2.24% |
IDXX | 31.29% | $34.21B | -20.95% | 0.00% |
LOCO | 31.15% | $311.17M | +15.73% | 0.00% |
IBRX | 29.80% | $2.35B | -55.43% | 0.00% |
BIIB | 29.35% | $20.69B | -35.95% | 0.00% |
SUNS | 29.27% | $152.60M | +0.62% | 5.45% |
SON | 28.56% | $4.72B | -16.48% | 4.37% |
CGEM | 28.40% | $510.23M | -46.63% | 0.00% |
ZTS | 28.37% | $73.06B | -3.07% | 1.10% |
DLR | 28.27% | $50.97B | +8.14% | 3.22% |
ARR | 28.10% | $1.42B | -4.17% | 15.49% |
CNMD | 27.77% | $1.82B | -21.76% | 1.37% |
LOW | 27.56% | $127.76B | -13.31% | 2.03% |
DECK | 27.37% | $17.56B | -27.17% | 0.00% |
PFSI | 27.34% | $5.22B | +10.55% | 1.08% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TNET | -28.06% | $3.91B | -40.35% | 1.28% |
TCTM | -22.37% | $3.22M | -84.87% | 0.00% |
KNSL | -21.46% | $10.68B | -11.58% | 0.14% |
BYD | -15.71% | $5.67B | +6.34% | 1.03% |
TS | -14.25% | $21.99B | +1.19% | 3.40% |
TEAM | -13.99% | $59.25B | +14.65% | 0.00% |
ALNY | -13.47% | $32.98B | +72.93% | 0.00% |
WKC | -13.36% | $1.61B | +7.63% | 2.41% |
PRPO | -12.50% | $10.06M | +12.68% | 0.00% |
ARLP | -12.15% | $3.43B | +33.47% | 10.48% |
LPTH | -11.72% | $87.55M | +50.34% | 0.00% |
TBBK | -10.78% | $2.62B | +69.43% | 0.00% |
OIS | -9.90% | $334.74M | -11.44% | 0.00% |
SKWD | -9.45% | $2.00B | +35.43% | 0.00% |
NNVC | -9.15% | $20.65M | +15.79% | 0.00% |
DMLP | -9.13% | $1.43B | -8.29% | 10.68% |
AON | -8.54% | $84.93B | +20.41% | 0.69% |
ALSN | -8.46% | $8.46B | +26.04% | 1.04% |
PULM | -8.30% | $27.76M | +363.41% | 0.00% |
BACK | -7.63% | $1.41M | -67.43% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CTA | -16.54% | $927.03M | 0.76% |
VIXY | -15.60% | $195.31M | 0.85% |
BTAL | -14.20% | $392.24M | 1.43% |
UUP | -11.20% | $332.64M | 0.77% |
USDU | -9.73% | $214.47M | 0.5% |
BILZ | -8.06% | $720.70M | 0.14% |
KMLM | -7.43% | $227.79M | 0.9% |
TAIL | -6.96% | $83.83M | 0.59% |
BOXX | -6.69% | $5.67B | 0.1949% |
TPMN | -5.98% | $33.27M | 0.65% |
USFR | -4.30% | $18.45B | 0.15% |
TFLO | -3.86% | $6.79B | 0.15% |
DBA | -3.81% | $845.19M | 0.93% |
USO | -3.39% | $891.33M | 0.6% |
ULST | -3.18% | $584.04M | 0.2% |
DBO | -3.04% | $190.57M | 0.77% |
EQLS | -2.82% | $6.31M | 1% |
BNO | -2.70% | $90.64M | 1% |
IBDQ | -2.39% | $3.19B | 0.1% |
DBE | -2.23% | $54.72M | 0.77% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SSP | <0.01% | $261.84M | -21.76% | 0.00% |
STG | -<0.01% | $29.37M | -42.04% | 0.00% |
PR | 0.01% | $9.83B | -19.20% | 4.04% |
HE | -0.01% | $1.91B | -3.57% | 0.00% |
IMNN | 0.01% | $13.95M | +14.91% | 0.00% |
AOUT | 0.03% | $172.56M | +51.40% | 0.00% |
PFBC | 0.03% | $1.12B | +10.61% | 3.37% |
HCI | -0.03% | $1.48B | +18.34% | 1.17% |
PSX | -0.04% | $52.52B | -19.02% | 3.58% |
SRE | 0.07% | $45.60B | +0.11% | 4.48% |
RILY | 0.07% | $130.22M | -79.55% | 11.67% |
AVAL | -0.08% | $1.04B | +23.66% | 4.21% |
DINO | -0.09% | $6.39B | -44.99% | 5.90% |
SU | 0.10% | $46.65B | +4.11% | 4.26% |
FOXA | 0.14% | $24.13B | +74.40% | 1.02% |
VHC | 0.14% | $35.27M | +26.25% | 0.00% |
AGX | 0.16% | $1.64B | +133.88% | 1.15% |
ATOM | -0.16% | $176.55M | -11.27% | 0.00% |
APPS | 0.16% | $362.27M | +24.10% | 0.00% |
FCNCA | 0.18% | $25.02B | +14.21% | 0.38% |
Current Value
$220.091 Year Return
Current Value
$220.091 Year Return
Yahoo
Morgan Stanley analyst David Bailey initiated coverage of ResMed (RMD) with an Overweight rating and $280 price target The company has a market-leading position in the obstructive sleep apnea market and valuations appear attractive at current levels, with a strong balance sheet position and the highest ROIC across the firm’s Australian Healthcare industry sector coverage, the analyst tells investors. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial
SeekingAlpha
Stock selection in life science tools & services, pharmaceuticals and distributors detracted from relative performance, as did an overweight in health care facilities.
Yahoo
Largest ever meta-analysis on the long-term benefits of CPAP therapy, published in The Lancet Respiratory Medicine, found that in people with sleep apnea, CPAP therapy lowered the overall chance of dying by 37% and the chance of heart-related death by 55%.SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the global leader in health technology focused on sleep, breathing, and care delivered in the home, today announced the publication of a landmark meta-analysis in The L
MarketWatch
ResMed Inc. stock falls Tuesday, underperforms market
Yahoo
Globus Medical currently awaits a strong cadence of product launches throughout the Musculoskeletal portfolio in the coming months of 2025.
SeekingAlpha
Read here for weekly updates on Dividend Champions, Contenders and Challengers, including changes, upcoming ex-dividend dates, and payment schedules.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
DUSB | 0.06% | $1.13B | 0.15% |
IEO | -0.19% | $574.63M | 0.4% |
PIN | 0.21% | $224.83M | 0.78% |
JAAA | -0.30% | $21.90B | 0.21% |
MINT | 0.31% | $13.20B | 0.35% |
UNG | 0.47% | $456.14M | 1.06% |
FMF | -0.69% | $155.13M | 0.95% |
COMT | 0.71% | $671.56M | 0.48% |
UGA | -0.76% | $85.26M | 0.97% |
TBIL | 0.84% | $5.28B | 0.15% |
BIL | -1.36% | $42.20B | 0.1356% |
USCI | -1.38% | $228.07M | 1.07% |
PXE | 1.54% | $88.05M | 0.63% |
KCCA | -1.56% | $108.74M | 0.87% |
KRBN | 1.56% | $180.36M | 0.85% |
SGOV | 1.64% | $38.60B | 0.09% |
TBLL | -1.81% | $2.05B | 0.08% |
AGZD | -1.85% | $139.24M | 0.23% |
INDY | 1.90% | $630.55M | 0.89% |
OILK | -1.92% | $64.75M | 0.69% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IHI | 44.56% | $4.72B | 0.4% |
XHE | 40.20% | $178.52M | 0.35% |
RSPH | 37.39% | $806.34M | 0.4% |
PHB | 35.50% | $331.57M | 0.5% |
OVT | 34.62% | $63.43M | 0.8% |
AOK | 34.61% | $627.93M | 0.15% |
ANGL | 34.29% | $3.21B | 0.25% |
SHYG | 33.54% | $6.46B | 0.3% |
HYDB | 33.25% | $1.62B | 0.35% |
SWAN | 33.06% | $250.64M | 0.49% |
SPHQ | 32.90% | $11.66B | 0.15% |
FXH | 32.86% | $985.80M | 0.62% |
HYGV | 32.62% | $1.45B | 0.37% |
SJNK | 32.60% | $4.97B | 0.4% |
USHY | 32.36% | $19.86B | 0.08% |
CEMB | 32.24% | $394.38M | 0.5% |
JNK | 32.21% | $7.87B | 0.4% |
HYXF | 32.20% | $185.51M | 0.35% |
BBHY | 32.10% | $940.71M | 0.07% |
HYG | 31.96% | $15.34B | 0.49% |